Announcements Trials
Browse Landscape

Phase

Phase 2 443Phase 1/2 157Phase 3 116Phase 1 74Phase NA 54Phase 4 6Phase 2/3 5Phase EARLY_PHASE1 2

Status

Completed 6

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 6

Sponsor

Cancer Type

Plasma cell 6Classical hematology 1

Conditions

Breast Neoplasms 49Neoplasms 36Prostatic Neoplasms 25Carcinoma, Non-Small-Cell Lung 25Polycystic Ovary Syndrome 16Pain 15Keratosis, Actinic 14Leukemia 12Colorectal Neoplasms 11Uterine Cervical Neoplasms 10Pancreatic Neoplasms 10Lung Neoplasms 10Leiomyoma 10Carcinoma, Hepatocellular 10Ovarian Neoplasms 9Neoplasm Metastasis 9Lymphoma, Follicular 9Carcinoma, Renal Cell 9Brain Neoplasms 9Neuroendocrine Tumors 8Arthritis, Rheumatoid 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Melanoma 7Kidney Neoplasms 7Head and Neck Neoplasms 7Colonic Neoplasms 7Cancer Pain 7Multiple Myeloma 6Lymphoma 6Liver Neoplasms 6

Interventions

Zoledronic Acid 2Lenalidomide 2Dexamethasone 2daratumumab 1carfilzomib 1apixaban 1Mesna 1Melphalan 1Interviews as Topic 1Hematopoietic Stem Cell Mobilization 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cyclophosphamide 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 4 × Has results × Multiple Myeloma × Clear all
NCT03934684 2026-05-11

Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

Amgen

Phase 4 Completed
101 enrolled 14 charts
Plasma cell

Multiple Myeloma

NCT05511428 2025-11-21

Home Based Daratumumab Administration for Patients With Multiple Myeloma

Thomas Jefferson University

Phase 4 Completed
20 enrolled 38 charts
Plasma cell

Multiple Myeloma

NCT00622505 2021-05-26

Z-MARK

Novartis

Phase 4 Completed
121 enrolled 15 charts
Plasma cell

Multiple Myeloma

NCT01731886 2020-02-05

Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma

Columbia University

Phase 4 Completed
60 enrolled 14 charts
Plasma cell

Multiple Myeloma

NCT02958969 2019-12-17

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Dana-Farber Cancer Institute

Phase 4 Completed
50 enrolled 5 charts
Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT00104104 2011-06-29

A Multiple Myeloma Trial in Patients With Bone Metastases

Novartis

Phase 4 Completed
179 enrolled 15 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡